30-day mortality | 1-year mortality | 5-year mortality | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age group | 2000–02 | 2008–10 | ORa (95% CI) | p | 2000–02 | 2008–10 | ORa (95%CI) | p | 2000–02 | 2008–10 | ORa (95%CI) | p | |
A | 25–54 (%,n) | 5.4% (60) | 3.9% (45) | 0.73 (0.49–1.08) | 0.12 | 14.4% (160) | 9.8% (114) | 0.68 (0.52–0.88) | < 0.01 | 32.1% (357) | 22.1% (256) | 0.62 (0.51–0.75) | < 0.01 |
Men | 55–64 (%,n) | 7.2% (172) | 4.8% (125) | 0.65 (0.51–0.82) | < 0.01 | 18.7% (446) | 14.3% (374) | 0.73 (0.62–0.85) | < 0.01 | 45.0% (1075) | 34.5% (901) | 0.64 (0.57–0.72) | < 0.01 |
65–74 (%,n) | 11.3% (645) | 8.0% (412) | 0.68 (0.60–0.78) | < 0.01 | 28.6% (1629) | 22.6% (1155) | 0.75 (0.66–0.78) | < 0.01 | 59.5% (3384) | 52.9% (2707) | 0.76 (0.70–0.82) | < 0.01 | |
75–84 (%,n) | 17.8% (1330) | 14.2% (1125) | 0.76 (0.70–0.83) | < 0.01 | 42.8% (3201) | 36.3% (2888) | 0.75 (0.71–0.80) | < 0.01 | 78.8% (5895) | 73.4% (5833) | 0.73 (0.67–0.78) | < 0.01 | |
85+ (%,n) | 30.3% (800) | 25.2% (1031) | 0.79 (0.71–0.88) | < 0.01 | 58.3% (1539) | 53.4% (2182) | 0.82 (0.74–0.90) | < 0.01 | 91.7% (2421) | 89.5% (3654) | 0.75 (0.63–0.89) | < 0.01 | |
Total (%,n) | 15.6% (3007) | 13.1% (2743) | 0.74 (0.70–0.79) | < 0.011 | 36.1% (6975) | 32.1% (6713) | 0.75 (0.72–0.78) | < 0.011 | 68.0% (13132) | 63.8% (13351) | 0.72 (0.69–0.76) | < 0.011 | |
B | 25–54 (%,n) | 4.7% (36) | 3.8% (31) | 0.81 (0.50–1.33) | 0.38 | 13.7% (104) | 10.5% (85) | 0.77 (0.56–1.05) | 0.10 | 26.7% (203) | 20.4% (166) | 0.72 (0.56–0.92) | < 0.01 |
Women | 55–64 (%,n) | 6.4% (76) | 5.8% (84) | 0.91 (0.66–1.25) | 0.57 | 19.3% (231) | 16.0% (231) | 0.79 (0.65–0.98) | 0.03 | 39.4% (470) | 35.4% (512) | 0.85 (0.72–0.99) | 0.055 |
65–74 (%,n) | 10.4% (389) | 8.1% (270) | 0.76 (0.64–0.90) | < 0.01 | 25.6% (957) | 21.1% (705) | 0.78 (0.70–0.87) | < 0.01 | 53.0% (1981) | 45.8% (1532) | 0.75 (0.69–0.83) | < 0.01 | |
75–84 (%,n) | 15.5% (1276) | 12.6% (1055) | 0.79 (0.72–0.86) | < 0.01 | 35.6% (2940) | 30.2% (2534) | 0.78 (0.73–0.83) | < 0.01 | 70.8% (5837) | 64.9% (5447) | 0.76 (0.71–0.81) | < 0.01 | |
85+ (%,n) | 23.6% (1323) | 20.1% (1616) | 0.82 (0.75–0.89) | < 0.01 | 50.8% (2843) | 46.1% (3710) | 0.83 (0.77–0.89) | < 0.01 | 87.3% (4887) | 85.3% (6864) | 0.84 (0.76–0.93) | < 0.01 | |
Total (%,n) | 15.9% (3100) | 13.9% (3056) | 0.79 (0.75–0.83) | < 0.011 | 36.2% (7075) | 33.0% (7465) | 0.79 (0.76–0.83) | < 0.011 | 68.5% (13378) | 65.9% (14521) | 0.78 (0.75–0.82) | < 0.011 | |
C | Differences men and women | ||||||||||||
Men∆2000–02 2008–10 | Women∆2000–02 2008–10 | ORb (95%CI) | p | Men∆2000–02 2008–10 | Women∆2000–02 2008–10 | ORb (95%CI) | p | Men ∆2000–02 2008–10 | Women∆2000–02 2008–10 | ORb (95%CI) | p | ||
25–54 | −1.5% | −0.9% | 1.13 (0.60–2.11) | 0.71 | −4.6% | −3.2% | 1.12 (0.75–1.68) | 0.58 | −10.0% | −6.3% | 1.15 (0.84–1.57) | 0.29 | |
55–64 | −2.4% | −0.6% | 1.40 (0.94–2.09) | 0.10 | −4.5% | −3.4% | 1.10 (0.85–1.41) | 0.48 | −10.5% | −4.0% | 1.32 (1.09–1.63) | < 0.01 | |
65–74 | −3.3% | −2.3% | 1.11 (0.90–1.36) | 0.34 | −5.1% | −4.5% | 1.09 (0.94–1.25) | 0.35 | −6.6% | −7.2% | 1.00 (0.89–1.13) | 0.99 | |
75–84 | −3.6% | −2.9% | 1.03 (0.91–1.16) | 0.67 | −6.5% | −5.5% | 1.03 (0.94–1.13) | 0.48 | −5.4% | − 5.1% | 1.05 (0.95–1.16) | 0.38 | |
85+ | −5.1% | −3.6% | 1.04 (0.90–1.19) | 0.62 | −4.9% | −4.7% | 1.01 (0.90–1.14) | 0.86 | −2.2% | −2.0% | 1.11 (0.91–1.34) | 0.29 | |
Total | −2.5% | −2.0% | 1.04 (0.97–1.13) | 0.291 | −4.0% | −3.2% | 1.05 (0.98–1.11) | 0.161 | −4.2% | −2.6% | 1.09 (1.02–1.15) | 0.011 |